share_log

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Freeman Roy Lester

SEC announcement ·  Jul 5, 2023 21:11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more